| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/20/2011 | CN101537068B Chinese medicine for treating angina |
| 07/20/2011 | CN101508684B Synthesis of cinepazide maleate |
| 07/20/2011 | CN101507777B Medicine composition for treating coronary heart disease and preparation method thereof |
| 07/20/2011 | CN101502610B Method for extracting veratrum alkaloid from Veratrum nigrum by supercritical carbon dioxide |
| 07/20/2011 | CN101491602B Traditional Chinese medicine for treating anus intestine disease |
| 07/20/2011 | CN101485744B Chinese medicinal composition for treating coronary heart disease |
| 07/20/2011 | CN101480404B Medicinal product of oryzanol and preparation method thereof |
| 07/20/2011 | CN101454286B Method for producing phenoxypyridine derivative |
| 07/20/2011 | CN101401844B Red sage root extract and injection |
| 07/20/2011 | CN101362728B Valsartan synthesis method |
| 07/20/2011 | CN101342236B Method for preparing red sage root extract, red sage root extract and medicament composition containing the same |
| 07/20/2011 | CN101337891B Nitric oxide donor type 3-butylphthalide derivates, method for preparing same and pharmaceutical use |
| 07/20/2011 | CN101322801B Use of Chinese medicinal composition in preparing medicament for treating dilated cardiomyopathy |
| 07/20/2011 | CN101305007B Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as PDE5 inhibitors |
| 07/20/2011 | CN101297669B Chitosan oral scented pieces and preparation thereof |
| 07/20/2011 | CN101279045B Medicament for curing arrhythmia and method of preparing the same |
| 07/20/2011 | CN101269138B Traditional Chinese medicine for treating hemorrhoid |
| 07/20/2011 | CN101260092B Method for preparing cinepazide maleate |
| 07/20/2011 | CN101244206B Pharmaceutical combination for treating cerebral thrombus and preparation thereof |
| 07/20/2011 | CN101181418B Medicine composition for curing arrhythmia and preparation method and detection method thereof |
| 07/20/2011 | CN101164566B Peony leaves total glycoside extract, its preparation method and application |
| 07/20/2011 | CN101152246B Pharmaceutical composition for cardiovascular and cerebrovascular diseases and method for preparing the same |
| 07/20/2011 | CN101084911B Notoginsenoside sodium freezing-dried emulsion and preparation method thereof |
| 07/20/2011 | CN101057890B Traditional Chinese medicinal composition for treating coronary heart disease and its preparation method, preparations and its application |
| 07/19/2011 | US7982067 Phenethanolamine derivatives for treatment of respiratory diseases |
| 07/19/2011 | US7982048 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7981894 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/19/2011 | US7981881 Fused heterocyclic compounds and use thereof |
| 07/19/2011 | US7981861 Method of performing angioplasty with a GLP-1 molecule |
| 07/19/2011 | US7981420 Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) |
| 07/19/2011 | CA2614700C Medicinal composition containing ginseng secondary glycosides, its preparation method and application |
| 07/19/2011 | CA2599415C Stable micronized candesartan cilexetil and methods for preparing thereof |
| 07/19/2011 | CA2477232C Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 07/19/2011 | CA2476186C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/19/2011 | CA2475818C Aryl ureas as kinase inhibitors |
| 07/19/2011 | CA2467046C Process for the manufacture of human mononuclear phagocytic leukocytes |
| 07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 07/19/2011 | CA2431606C Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 07/14/2011 | WO2011085301A1 Biomatrices to attract and retain regenerative and reparative cells |
| 07/14/2011 | WO2011085103A2 Plasma kallikrein binding proteins |
| 07/14/2011 | WO2011084733A1 Method of treating atrial fibrillation |
| 07/14/2011 | WO2011084046A1 Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atherosclerosis and cardiovascular disease |
| 07/14/2011 | WO2011083275A1 Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof |
| 07/14/2011 | WO2011082732A1 Sphingosine kinase inhibitors |
| 07/14/2011 | WO2011082694A1 Targeted delivery slow-release stent of gene pharmaceutical for revascularization |
| 07/14/2011 | WO2011048033A3 Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
| 07/14/2011 | WO2011031111A3 Alkoxy indole-3-acetic acid derivative acting as ppar α/γ/δ agonists, preparation method thereof, and pharmaceutical composition containing same as active ingredient |
| 07/14/2011 | WO2011028737A3 Bisphosphonate compositions and methods for treating heart failure |
| 07/14/2011 | WO2011028016A3 Pharmaceutical preparation comprising beta-adrenergic blockers and angiotensin ii receptor blockers |
| 07/14/2011 | WO2011025883A3 Natural igm antibodies |
| 07/14/2011 | WO2011022071A3 Cardiac compositions |
| 07/14/2011 | WO2011004040A3 Use of captopril as a cardioprotector and anti-inflammatory for heart trouble associated with arterial hypertension |
| 07/14/2011 | WO2010049709A8 Therapeutic compositions comprising phenolic acids for treating conditions related to inappropriate platelet aggregation |
| 07/14/2011 | US20110173711 eNos Mutations Useful for Gene Therapy and Therapeutic Screening |
| 07/14/2011 | US20110173709 Ectopic, orthotopic model for revascularization and tumor assessment |
| 07/14/2011 | US20110172310 Di-fluoro containing compounds as cysteine protease inhibitors |
| 07/14/2011 | US20110172309 Galenic formulations of organic compounds |
| 07/14/2011 | US20110172308 Antagonsim of PGF2a Receptor to Treat Hyertension Characterized by Activation of the Renin-Angiotensin-Aldosterone System |
| 07/14/2011 | US20110172306 Creatine ester pronutrient compounds and formulations |
| 07/14/2011 | US20110172297 Oxopiperdinyl And Pyranyl Sulfonamides and Pharmaceutical Compositions Thereof |
| 07/14/2011 | US20110172292 Antidote oligomers |
| 07/14/2011 | US20110172282 Use of spiro-oxindole compounds as therapeutic agents |
| 07/14/2011 | US20110172274 Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity |
| 07/14/2011 | US20110172271 Urinary Triaosylceramide (GB3) as a Marker of Cardiac Disease |
| 07/14/2011 | US20110172270 2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 07/14/2011 | US20110172266 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/14/2011 | US20110172265 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 07/14/2011 | US20110172261 DIBENZO[f,h]ISOQUINOLINE DERIVATIVES |
| 07/14/2011 | US20110172246 1-(2-phenoxymethylphenyl)piperazine compounds |
| 07/14/2011 | US20110172244 Compounds and compositions as modulators of gpr119 activity |
| 07/14/2011 | US20110172235 Substituted triazolophthalazine derivatives |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172228 Kinase inhibitors and methods of use |
| 07/14/2011 | US20110172216 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use |
| 07/14/2011 | US20110172209 3h-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of gpr81 receptor disorders |
| 07/14/2011 | US20110172198 TGR5 Modulators And Methods Of Use Thereof |
| 07/14/2011 | US20110172195 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| 07/14/2011 | US20110172191 Thieno-pyridine derivatives as mek inhibitors |
| 07/14/2011 | US20110172190 Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
| 07/14/2011 | US20110172186 Inhibitors of fatty acid amide hydrolase |
| 07/14/2011 | US20110172176 Crystal structures of sglt2 inhibitors and processes for preparing same |
| 07/14/2011 | US20110172172 Method of Treating Neurological Conditions with Cardiac Glycoside |
| 07/14/2011 | US20110172157 Somatostatin analogues |
| 07/14/2011 | US20110172144 Methods for increasing expression of serca2a in cardiac muscle |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171317 Method for inhibiting accumulation of visceral fat |
| 07/14/2011 | US20110171311 Stable hydrogel compositions including additives |
| 07/14/2011 | US20110171308 Ph-sensitive solid pharmaceutical composition for oral preparation and preparation method thereof |
| 07/14/2011 | US20110171292 Peptide compositions and methods of use |
| 07/14/2011 | US20110171290 Inhibition of angiogenesis and tumor metastasis |
| 07/14/2011 | US20110171275 Gastroretentive drug delivery system, preparation method and use thereof |
| 07/14/2011 | US20110171270 Novel solid state forms of laquinimod and its sodium salt |
| 07/14/2011 | US20110171268 Uricase compositions and methods of use |
| 07/14/2011 | US20110171247 Novel vascular endothelial growth factor expression inhibitors |
| 07/14/2011 | US20110171214 Efficient well being assessment and improved treatment protocol |
| 07/14/2011 | US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 07/14/2011 | US20110171197 Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same |
| 07/14/2011 | US20110171196 Methods of treatment and uses for camkii and its interaction with hdacs and calpain |